141 related articles for article (PubMed ID: 38194091)
1. Expectant management versus systemic methotrexate in the management of persistent pregnancy of unknown location, a seven-year retrospective analysis.
Elshamy E; Zakaria Y; Alajami F; Fathy M
Arch Gynecol Obstet; 2024 Mar; 309(3):1035-1041. PubMed ID: 38194091
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis.
Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D
Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate versus expectant management in ectopic pregnancy: a meta-analysis.
Naveed AK; Anjum MU; Hassan A; Mahmood SN
Arch Gynecol Obstet; 2022 Mar; 305(3):547-553. PubMed ID: 34524502
[TBL] [Abstract][Full Text] [Related]
5. Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success.
Wu J; Ludlow JP; De Vries B; Black K; Beale P
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):469-74. PubMed ID: 25287564
[TBL] [Abstract][Full Text] [Related]
6. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial.
Jurkovic D; Memtsa M; Sawyer E; Donaldson AN; Jamil A; Schramm K; Sana Y; Otify M; Farahani L; Nunes N; Ambler G; Ross JA
Ultrasound Obstet Gynecol; 2017 Feb; 49(2):171-176. PubMed ID: 27731538
[TBL] [Abstract][Full Text] [Related]
7. How feasible is expectant management of interstitial ectopic pregnancy?
Poon LC; Emmanuel E; Ross JA; Johns J
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):317-21. PubMed ID: 23868814
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of health-related quality of life in women with ectopic pregnancy or pregnancy of unknown location treated with systemic methotrexate or expectant management.
van Mello NM; Mol F; Hajenius PJ; Ankum WM; Mol BW; van der Veen F; van Wely M
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():1-5. PubMed ID: 26125101
[TBL] [Abstract][Full Text] [Related]
9. Unruptured tubal pregnancy: different treatments for early and late diagnosis.
Elito Junior J; Camano L
Sao Paulo Med J; 2006 Nov; 124(6):321-4. PubMed ID: 17322952
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-treated ectopic pregnancy: beta human chorionic gonadotropin serum changes as a success predictor using a mathematical model validation.
Kovaleva A; Irishina N; Pereira A; Cuesta-Guardiola T; Ortiz-Quintana L
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():35-38. PubMed ID: 27936449
[TBL] [Abstract][Full Text] [Related]
11. Expectant management of tubal pregnancies with human chorionic gonadotropin up to 2000 mIU/mL.
Kugelman N; Cohen B; Yossef F; Margieh N; Regev N; Shani U; Bart Y
Int J Gynaecol Obstet; 2024 Mar; 164(3):1094-1100. PubMed ID: 37776069
[TBL] [Abstract][Full Text] [Related]
12. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
[TBL] [Abstract][Full Text] [Related]
13. [Use of methotrexate in the ectopic pregnancy and pregnancy of unknown location].
Racková J; Driák D; Neumannová H; Hurt K; Sehnal B; Halaška M
Ceska Gynekol; 2016 Apr; 81(2):140-6. PubMed ID: 27457397
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate success rates in progressing ectopic pregnancies: a reappraisal.
Cohen A; Zakar L; Gil Y; Amer-Alshiek J; Bibi G; Almog B; Levin I
Am J Obstet Gynecol; 2014 Aug; 211(2):128.e1-5. PubMed ID: 24657132
[TBL] [Abstract][Full Text] [Related]
15. Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial.
Barnhart KT; Hansen KR; Stephenson MD; Usadi R; Steiner AZ; Cedars MI; Jungheim ES; Hoeger KM; Krawetz SA; Mills B; Alston M; Coutifaris C; Senapati S; Sonalkar S; Diamond MP; Wild RA; Rosen M; Sammel MD; Santoro N; Eisenberg E; Huang H; Zhang H;
JAMA; 2021 Aug; 326(5):390-400. PubMed ID: 34342619
[TBL] [Abstract][Full Text] [Related]
16. Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management.
Kirk E; Van Calster B; Condous G; Papageorghiou AT; Gevaert O; Van Huffel S; De Moor B; Timmerman D; Bourne T
Acta Obstet Gynecol Scand; 2011 Mar; 90(3):264-72. PubMed ID: 21306315
[TBL] [Abstract][Full Text] [Related]
17. Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?
Nguyen Q; Kapitz M; Downes K; Silva C
Am J Obstet Gynecol; 2010 Jun; 202(6):630.e1-5. PubMed ID: 20510964
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of expectant management versus methotrexate in tubal ectopic pregnancy: a double-blind randomized trial.
Silva PM; Araujo Júnior E; Cecchino GN; Elito Júnior J; Camano L
Arch Gynecol Obstet; 2015 Apr; 291(4):939-43. PubMed ID: 25315383
[TBL] [Abstract][Full Text] [Related]
19. Optimal treatment for women with a persisting pregnancy of unknown location, a randomized controlled trial: The ACT-or-NOT trial.
Barnhart KT; Sammel MD; Stephenson M; Robins J; Hansen KR; Youssef WA; Santoro N; Eisenberg E; Zhang H;
Contemp Clin Trials; 2018 Oct; 73():145-151. PubMed ID: 30243810
[TBL] [Abstract][Full Text] [Related]
20. Comparison of single- and double-dose methotrexate protocols for treatment of pregnancy of unknown location.
Piróg MM; Pulka A; Urbaniec P; Jach R
Eur J Obstet Gynecol Reprod Biol; 2024 Jul; 298():171-174. PubMed ID: 38762953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
